Cancer Research Journal

| Peer-Reviewed |

Epidemiological and Histopathological Features of Small Intestine Cancer in Cameroon: About 47 Cases

Received: Aug. 25, 2019    Accepted: Sep. 09, 2019    Published: Oct. 09, 2019
Views:       Downloads:

Share This Article

Abstract

Bakground: The small intestine represents the longest part of the digestive tract. The small bowel cancer is rare, but is increasing worldwide. Methods: Data was analysed retrospectively from the medical records concerning cancer of the small intestine histologically proven, from different histopathology laboratories in Cameroon, for 13 years (2004-2016). The variables studied were the frequency, age, gender, risk factors, location and histopathologic type Results: 3.34% (47 cases /1407) of digestive cancers observed during the period of study. There were 23 female and 24 male patients, with a mean age of 49,77±15,84 (11 to 78 years), the sex ratio of men to women 1.04. The main risk factors were Intestinal polyp, adenomatous polyp and polyposis with 6 cases 25.00%, respectively. The ileum location was the most represented with 47.37%. Adenocarcinoma was the most frequent histological type with 33 cases (70.21%). Conclusion: Small intestine cancer is the sixth malignant tumor of the digestive tract in Cameroon. The mean age of onset is 49.77 years with a relative male predominance. The most common histological type is adenocarcinoma.

DOI 10.11648/j.crj.20190704.13
Published in Cancer Research Journal ( Volume 7, Issue 4, December 2019 )
Page(s) 136-142
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Small Intestine, Small Bowel, Cancers, Epidemiology, Histopathology, Cameroon

References
[1] Raghav K, Overman MJ (2013) Small bowel adernocarcinomas existing evidence and evolving paradigms. Nat Rev Clin Oncol 10: 534-544.
[2] Siegel RL, Miller KD, Jemal A (2018) Cancer statistics 2018. CA Cancer J Clin 68: 7-30.
[3] Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence—SEER 18 Regs Research Data+Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (1973–2013 Varying)—Linked To County Attributes—Total U.S., 1969–2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, Released April 2016, Based on the November 2015. Available online: https://seer.cancer.gov/statfacts/html/smint.html (accessed on 15 February 2019).
[4] Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P. Cancer Incidence in Five Continents Vol. IX. Lyon: IARC, IARC Scientific Publication, No. 160, 2007.
[5] Haselkorn T, Whittemore AS, Lilienfeld DE. Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences. Cancer Causes Control. 2005; 16: 781-787.
[6] Barsouk A, Rawla P, Barsouk A, Thandra KC. Epidemiology of Cancers of the Small Intestine: Trends, Risk Factors, and Prevention. Med. Sci. 2019; 7: 46; doi: 10.3390/medsci7030046.
[7] Halima A, Maha M, Issam L, Hind M, Hassan E. Les tumeurs malignes primitives de l'intestin grêle: aspects cliniques et thérapeutiques de 27 patients. Pan African Medical Journal. 2011; 8: 18.
[8] Ayite A, Dosseh E, Etey K, Senah K, Napo-Koura K, James K. Les Cancers De L’intestin Grêle Au Chu De Lomé (Togo). A Propos De 8 Cas Observes En 10 Ans. Médecine d'Afrique Noire: 1996, 43 (10): 535-7.
[9] Raharisolo Vololonantenaina CR, Dina TJN, Ravalisoa A. Un cancer peu fréquent: celui de l’intestin grêle. A propos de 25 cas diagnostiqués à l’Institut Pasteur de Madagascar de 1992 à 2001. Arch Inst Pasteur de Madagascar. 2003; 69 (1 & 2): 82-86.
[10] Martínez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology. 2009; 136 (3): 832-41.
[11] Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet. 1988; 1: 1149–1151.
[12] Ribeiro MB, Greenstein AJ, Heimann TM, Yamazaki Y, Aufses AH Jr. Adenocarcinoma of the small intestine in Crohn’s disease. Surg Gynecol Obstet. 1991173: 343-349.
[13] Carbonnel F, Grollet-Bioul L, Brouet JC, et al. Are complicated forms of celiac disease cryptic T-cell lymphomas? Blood 1998; 92: 3879-3886.
[14] Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, et al. Small bowel cancer in the United States: Changes in epidemiology, treatment, and survival over the last 20 years. Ann. Surg. 2009; 249: 63–71.
[15] Moon YW, Rha SY, Shin SJ, Chang H, Shim HS, Roh JK. Adenocarcinoma of the small bowel at a single Korean institute: Management and prognosticators. J. Cancer Res. Clin. Oncol. 2010; 136: 387–394.
[16] Ngowe Ngowe M, Essomba A, Angwafo III F, Binam F, Sosso AM. Les tumeurs de l’intestin grele a l’hopital general de yaounde: à propos de 10 cas. Médecine d'Afrique noire 48 (12): 491_495.
[17] Collins, J. T.; Badireddy, M. Anatomy, Abdomen and Pelvis, Small Intestine. In StatPearls; StatPearls Publishing LLC.: Treasure Island, FL, USA, 2018.
[18] Neugut, A. I.; Jacobson, J. S.; Suh, S.; Mukherjee, R.; Arber, N. The epidemiology of cancer of the small bowel. Cancer Epidemiol. Biomark. Prev. 1998, 7, 243–251.
[19] Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-249.
[20] Canadian Cancer Society. Canadian Cancer Statistics 2009. Canadian Cancer Society, Toronto, Canada, 2009.
[21] Lien G, Mori M, Enjoji M. Primary carcinoma of the small intestine. A clinicopathologic and immunohistochemical study. Cancer. 1988; 61: 316-323.
[22] Lowenfels AB. Why are small-bowel tumours so rare? Lancet. 1973; 1: 24-25.
[23] Arber N, Neugut AI, Weinstein IB, Holt P. Molecular genetics of small bowel cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 745-748.
[24] Gabos S, Berkel J, Band P, Robson D, Whittaker H. Small bowel cancer in Western Canada. International Journal of Epidemiology. 1993; 22: 198-206.
[25] Turowski G, Abasson D. Primary malignant lymphoma of the intestine. The American Journal of Surgery. 1995; 169: 433-441.
[26] Sanders LM, Henderson CE, Hong MY, Barhoumi R, Burghardt RC, Carroll RJ, Turner ND, Chapkin RS, Lupton JR. Pro-oxidant environment of the colon compared to the small intestine may contribute to greater cancer susceptibility. Cancer Lett 2004; 208: 155-161.
[27] Terada T. Malignant tumors of the small intestine: A histopathologic study of 41 cases among 1,312 consecutive specimens of small intestine. Int J Clin Exp Pathol 2012; 5 (3): 203-209.
[28] Rabbani K, Narjis Y, Fouad, Samlani Z, Difaa A, et al. Primary malignancies of the small bowel at the Marrakech Teaching Hospital: a report of 52 cases. J. Afr. Cancer. 2012; 4: 84-88.
[29] Cancer Registration Statistics, England Statistical Bulletins. Available online: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases (accessed on 16 February 2019).
[30] Haoues N, Mabrouk M, Zaafouri H, Noomene R, Bouhafa A, et al. Primary cancers of the small bowel: About 20 cases. Open Journal of Gastroenterology. 2014; 4: 81-87.
[31] Gill SS, Heuman DM, Mihas AA. Small intestinal neoplasms. J Clin Gastroenterol 2001; 33: 267-282.
[32] Bjork KJ, Davis CJ, Nagorney DM, Mucha P Jr. Duodenal villous tumors. Arch Surg 1990; 125: 961-965.
[33] Schottenfeld D, Beebe-Dimmer JL, Vigneau FD. The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol 2009; 19: 58-69.
[34] Hassan C, Gimeno-García A, Kalager M, et al. Systematic review with meta-analysis: the incidence of advanced neoplasia after polypectomy in patients with and without low-risk adenomas. Aliment Pharmacol Ther. 2014; 39 (9): 905-12.
[35] Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
[36] De Rosa M, Pace U, Rega D, Costabile V, Duraturo F, et al. Genetics, diagnosis and management of colorectal cancer (Review). Oncol. Rep. 2015; 34: 1087–1096.
[37] Offerhaus GJ, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992, 102, 1980–1982.
[38] Shenoy S. Genetic risks and familial associations of small bowel carcinoma. World J. Gastrointest. Oncol. 2016; 8: 509–519.
[39] Kadmon M, Tandara A, Herfarth C. Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Polyposis Register. Int J Colorectal Dis 2001; 16: 63-75.
[40] Lowenfels AB, Sonni A. Distribution of small bowel tumors. Cancer Lett. 1977; 3: 83-86.
[41] Chow WH, Linet MS, McLaughlin JK, Hsing AW, Chien HT, Blot WJ. Risk factors for small intestine cancer. Cancer Causes Control 1993; 4: 163-169.
[42] Wu AH, Yu MC, Mack TM. Smoking, alcohol use, dietary factors and risk of small intestinal adenocarcinoma. Int J Cancer. 1997; 70: 512-517.
[43] International Agency for Research on Cancer. List of Classifications by cancer sites with sufficient or limited evidence in humans, Volumes 1 to 117. Accessed January 2017.
[44] Chen CC, Neugut AI, Rotterdam H. Risk factors for adenocarcinomas and malignant carcinoids of the small intestine: preliminary findings. Cancer Epidemiol Biomarkers Prev 1994; 3: 205-207.
[45] Negri E, Bosetti C, La Vecchia C, Fioretti F, Conti E, Franceschi S. Risk factors for adenocarcinoma of the small intestine. Int J Cancer 1999; 82: 171-174.
[46] Hassan MM, Phan A, Li D, Dagohoy CG, Leary C, Yao JC. Risk factors associated with neuroendocrine tumors: A U.S.- based case-control study. Int J Cancer 2008; 123: 867-873.
[47] Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, et al. Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis. Br. J. Cancer. 2015; 112: 580–593.
[48] Kodaira C, Osawa S, Mochizuki C, Sato Y, Nishino M, Yamada T, Takayanagi Y, Takagaki K, Sugimoto K, Kanaoka S, Furuta T, Ikuma M. A case of small bowel adenocarcinoma in a patient with Crohn's disease detected by PET/CT and double-balloon enteroscopy. World J Gastroenterol 2009; 15: 1774-1778.
[49] Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 357: 1731-1743.
[50] Ripley D, Weinerman BH. Increased incidence of second malignancies associated with small bowel adenocarcinoma. Can J Gastroenterol 1997; 11: 65-68.
[51] Hatzaras I, Palesty JA, Abir F, Sullivan P, Kozol RA, et al. Small-Bowel Tumors: Epidemiologic and Clinical Characteristics of 1260 Cases From the Connecticut Tumor Registry. Arch Surg. 2007; 142: 229-235.
[52] Ross RK, Hartnett NM, Bernstein L, Henderson BE. Epidemiology of adenocarcinomas of the small intestine: is bile a small bowel carcinogen? Br J Cancer. 1991; 63: 143-145.
Cite This Article
  • APA Style

    Jean Paul Ndamba Engbang, Servais Eloumou, Amadou Fewou, Clémentine Essaga Essaga, Bruno Djimeli Djougmo, et al. (2019). Epidemiological and Histopathological Features of Small Intestine Cancer in Cameroon: About 47 Cases. Cancer Research Journal, 7(4), 136-142. https://doi.org/10.11648/j.crj.20190704.13

    Copy | Download

    ACS Style

    Jean Paul Ndamba Engbang; Servais Eloumou; Amadou Fewou; Clémentine Essaga Essaga; Bruno Djimeli Djougmo, et al. Epidemiological and Histopathological Features of Small Intestine Cancer in Cameroon: About 47 Cases. Cancer Res. J. 2019, 7(4), 136-142. doi: 10.11648/j.crj.20190704.13

    Copy | Download

    AMA Style

    Jean Paul Ndamba Engbang, Servais Eloumou, Amadou Fewou, Clémentine Essaga Essaga, Bruno Djimeli Djougmo, et al. Epidemiological and Histopathological Features of Small Intestine Cancer in Cameroon: About 47 Cases. Cancer Res J. 2019;7(4):136-142. doi: 10.11648/j.crj.20190704.13

    Copy | Download

  • @article{10.11648/j.crj.20190704.13,
      author = {Jean Paul Ndamba Engbang and Servais Eloumou and Amadou Fewou and Clémentine Essaga Essaga and Bruno Djimeli Djougmo and Gilbert Ateba and Godefroy Simo and André Moune},
      title = {Epidemiological and Histopathological Features of Small Intestine Cancer in Cameroon: About 47 Cases},
      journal = {Cancer Research Journal},
      volume = {7},
      number = {4},
      pages = {136-142},
      doi = {10.11648/j.crj.20190704.13},
      url = {https://doi.org/10.11648/j.crj.20190704.13},
      eprint = {https://download.sciencepg.com/pdf/10.11648.j.crj.20190704.13},
      abstract = {Bakground: The small intestine represents the longest part of the digestive tract. The small bowel cancer is rare, but is increasing worldwide. Methods: Data was analysed retrospectively from the medical records concerning cancer of the small intestine histologically proven, from different histopathology laboratories in Cameroon, for 13 years (2004-2016). The variables studied were the frequency, age, gender, risk factors, location and histopathologic type Results: 3.34% (47 cases /1407) of digestive cancers observed during the period of study. There were 23 female and 24 male patients, with a mean age of 49,77±15,84 (11 to 78 years), the sex ratio of men to women 1.04. The main risk factors were Intestinal polyp, adenomatous polyp and polyposis with 6 cases 25.00%, respectively. The ileum location was the most represented with 47.37%. Adenocarcinoma was the most frequent histological type with 33 cases (70.21%). Conclusion: Small intestine cancer is the sixth malignant tumor of the digestive tract in Cameroon. The mean age of onset is 49.77 years with a relative male predominance. The most common histological type is adenocarcinoma.},
     year = {2019}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Epidemiological and Histopathological Features of Small Intestine Cancer in Cameroon: About 47 Cases
    AU  - Jean Paul Ndamba Engbang
    AU  - Servais Eloumou
    AU  - Amadou Fewou
    AU  - Clémentine Essaga Essaga
    AU  - Bruno Djimeli Djougmo
    AU  - Gilbert Ateba
    AU  - Godefroy Simo
    AU  - André Moune
    Y1  - 2019/10/09
    PY  - 2019
    N1  - https://doi.org/10.11648/j.crj.20190704.13
    DO  - 10.11648/j.crj.20190704.13
    T2  - Cancer Research Journal
    JF  - Cancer Research Journal
    JO  - Cancer Research Journal
    SP  - 136
    EP  - 142
    PB  - Science Publishing Group
    SN  - 2330-8214
    UR  - https://doi.org/10.11648/j.crj.20190704.13
    AB  - Bakground: The small intestine represents the longest part of the digestive tract. The small bowel cancer is rare, but is increasing worldwide. Methods: Data was analysed retrospectively from the medical records concerning cancer of the small intestine histologically proven, from different histopathology laboratories in Cameroon, for 13 years (2004-2016). The variables studied were the frequency, age, gender, risk factors, location and histopathologic type Results: 3.34% (47 cases /1407) of digestive cancers observed during the period of study. There were 23 female and 24 male patients, with a mean age of 49,77±15,84 (11 to 78 years), the sex ratio of men to women 1.04. The main risk factors were Intestinal polyp, adenomatous polyp and polyposis with 6 cases 25.00%, respectively. The ileum location was the most represented with 47.37%. Adenocarcinoma was the most frequent histological type with 33 cases (70.21%). Conclusion: Small intestine cancer is the sixth malignant tumor of the digestive tract in Cameroon. The mean age of onset is 49.77 years with a relative male predominance. The most common histological type is adenocarcinoma.
    VL  - 7
    IS  - 4
    ER  - 

    Copy | Download

Author Information
  • Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon; Laquintinie Hospital of Douala, Douala, Cameroon

  • Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon; Douala Gyneco - Pediatric Hospital, Douala, Cameroon

  • Douala General Hospital, Douala, Cameroon; Faculty of Medicine and Biomedical Sciences, The University of Yaoundé I, Yaoundé, Cameroon

  • Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon

  • Laquintinie Hospital of Douala, Douala, Cameroon

  • Douala Gyneco - Pediatric Hospital, Douala, Cameroon; Pravilna Laboratory, Douala, Cameroon

  • Bio-Medical and Cancer Center of Bafoussam, Bafoussam, Cameroon

  • Anapathos Laboratory, Douala, Cameroon

  • Section